Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome Analysis Reveal Candidate Genes and Pathways Responses to Lactate Dehydrogenase Inhibition (Oxamate) in Hyperglycemic Human Renal Proximal Epithelial Tubular Cells. | Front Endocrinol (Lausanne) | 2022 | 35370938 | PubTator, text mining | PubMed |
| Different Complement Activation Pathways Underly Cognitive Impairment and Type 2 Diabetes Mellitus Combined With Cognitive Impairment. | Front Aging Neurosci | 2022 | 35370615 | PubTator, text mining | PubMed |
| A familial case of periodontal Ehlers-Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R. | J Dermatol | 2022 | 35365885 | PubTator, text mining | PubMed |
| Clinical and translational values of spatial transcriptomics. | Signal Transduct Target Ther | 2022 | 35365599 | PubTator, text mining | PubMed |
| Domain-Dependent Evolution Explains Functional Homology of Protostome and Deuterostome Complement C3-Like Proteins. | Front Immunol | 2022 | 35359984 | PubTator, text mining | PubMed |
| Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. | Sci Rep | 2022 | 35338216 | PubTator, text mining | PubMed |
| Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19. | Viruses | 2022 | 35336960 | PubTator, text mining | PubMed |
| A role for complement blockade in kidney transplantation. | Cell Mol Immunol | 2022 | 35332298 | PubTator, text mining | PubMed |
| Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease. | J Pers Med | 2022 | 35330331 | PubTator, text mining | PubMed |
| Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients. | J Clin Med | 2022 | 35330001 | PubTator, text mining | PubMed |
| Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain. | Int J Mol Sci | 2022 | 35328462 | PubTator, text mining | PubMed |
| MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors. | Biomedicines | 2022 | 35327430 | PubTator, text mining | PubMed |
| The Proteome of Antibody-Mediated Rejection: From Glomerulitis to Transplant Glomerulopathy. | Biomedicines | 2022 | 35327371 | PubTator, text mining | PubMed |
| Components of the Lectin Pathway of Complement in Solid Tumour Cancers. | Cancers (Basel) | 2022 | 35326694 | PubTator, text mining | PubMed |
| The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. | Cells | 2022 | 35326456 | PubTator, text mining | PubMed |
| Synthesis of Nanocomposite TiSiCN Coatings by Titanium Evaporation and Organosilicon Compound Activation in Hollow Cathode Arc Discharge. | Membranes (Basel) | 2022 | 35323796 | PubTator, text mining | PubMed |
| B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications. | Front Immunol | 2022 | 35320934 | PubTator, text mining | PubMed |
| Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. | Arthritis Rheumatol | 2022 | 35315244 | PubTator, text mining | PubMed |
| Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing. | Proc Natl Acad Sci U S A | 2022 | 35312359 | PubTator, text mining | PubMed |
| Digital Spatial Profiling of Individual Glomeruli From Patients With Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. | Front Immunol | 2022 | 35309370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=40